Clinical trial
Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of…
NCT00388609 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00388609 |
|---|---|
| Title | Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects |
| Official title | A Randomized, Double-blind, Placebo-Controlled, Parallel Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 in Obese and High Risk Overweight Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | BMS-646256, Placebo |
| Enrollment | 705 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Apr 1, 2009 |
| First posted | Oct 17, 2006 |
| Last update posted | Sep 17, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: